5/29/2013

The FDA has cleared iTraumaCare to market its iTClamp Hemorrhage Control System, which is used to halt acute bleeding in traumatic-injury patients in seconds. The device, which already is available commercially in Canada, is set to be released in the U.S. within 30 to 45 days.

Related Summaries